The questions that take an hour elsewhere — answered in one click.
TheraRadar is a competitive intelligence platform for pharma and biotech. Search any drug, company, or target — and get the answer with the live data behind it.
Questions TheraRadar answers
When does Keytruda’s patent expire?
Patent expiry dates, exclusivity windows, and biosimilar timelines from the Orange and Purple Books.
Open on TheraRadar →Any GLP-1 / obesity readouts coming up?
Search "obesity" or "GLP-1" in the filter box. Combine with sponsor (Lilly, Novo) for tighter cuts.
Open on TheraRadar →What’s reading out at AstraZeneca in the next 6 months?
Filter by sponsor → window: Next 6 months. Reveals their full near-term catalyst slate in one screen.
Open on TheraRadar →What drugs were approved this year?
Browse FDA approvals indexed by sponsor, indication, modality, and approval date.
Open on TheraRadar →What does the competitive landscape for IL-23 look like?
Approved drugs, pipeline assets, sponsors, and combination strategies for the IL-23 target.
Open on TheraRadar →What’s happening in cell & gene therapy?
CAR-T, AAV, CRISPR, and other CGT programs indexed by sponsor, modality, indication, and clinical phase.
Open on TheraRadar →Try any of these at theraradar.com →
Live data from public sources
Built on FDA approvals, ClinicalTrials.gov, SEC filings, and the Orange and Purple Books. Used by business development, competitive intelligence, medical affairs, and translational research teams across pharma and biotech.